AVO refinancing deal delayed again

Investment

Advanced Oncotherapy (AVO) has announced further delays to its recapitalisation plans. The proton beam therapy developer had been expecting an initial tranche of funding in…

You must be a HM Subscriber to view this content.

Subscribe Now »